血浆多不饱和脂肪酸纵向轨迹与成年早期精神病谱系结局的关联
该研究基于ALSPAC队列,在7、15、17、24岁测量血浆omega-6/omega-3比值和DHA,采用曲线增长混合模型评估轨迹,并在24岁评估精神病谱系结局。持续高omega-6/omega-3比值和持续低DHA轨迹与精神病体验数量及阴性症状评分增加相关,但与精神病体验和精神病性障碍的关联在调整协变量后减弱。
要点
- 持续高omega-6/omega-3比值与精神病体验数量(β=0.41)和阴性症状评分(β=0.43)增加相关。
- 持续低DHA轨迹与精神病体验数量(β=0.45)和阴性症状评分(β=0.35)增加相关。
- 持续高比值和低DHA与精神病性障碍的关联在调整协变量后无统计学意义。
核心结论
- 持续高omega-6/omega-3比值和持续低DHA轨迹与成年早期精神病体验数量及阴性症状评分增加相关,但与精神病性障碍的关联在调整协变量后减弱。
研究设计与样本
- 研究基于ALSPAC(Avon Longitudinal Study of Parents and Children)队列,在7、15、17、24岁用核磁共振波谱法测量血浆omega-6/omega-3比值和DHA(占总脂肪酸百分比)。
- 采用曲线增长混合模型评估经体质指数调整的轨迹,结局在24岁评估。
- 精神病体验、风险精神状态、精神病性障碍和精神病体验数量用Psychosis-Like Symptoms访谈评估(n=3635;女性2247人,占61.8%)。
- 阴性症状评分用Community Assessment of Psychic Experiences评估(n=3484;女性2161人,占62.0%)。
- 关联分析调整了性别、种族、父母社会阶层和累积吸烟饮酒。
主要发现
- 相对于稳定平均水平,持续高omega-6/omega-3比值轨迹与精神病体验(aOR=1.63,95%CI=0.92-2.89)和精神病性障碍(aOR=1.69,95%CI=0.71-4.07)的关联在调整协变量后减弱。
- 持续低DHA轨迹与精神病体验(aOR=1.42,95%CI=0.84-2.37)和精神病性障碍(aOR=1.14,95%CI=0.49-2.67)的关联在调整协变量后减弱。
- 调整后,持续高omega-6/omega-3比值与精神病体验数量增加(β=0.41,95%CI=0.05-0.78)和阴性症状评分增加(β=0.43,95%CI=0.14-0.72)相关。
- 调整后,持续低DHA与精神病体验数量增加(β=0.45,95%CI=0.14-0.76)和阴性症状评分增加(β=0.35,95%CI=0.12-0.58)相关。
临床怎么用
- 在临床中可关注个体发育期多不饱和脂肪酸状态,尤其是持续高omega-6/omega-3比值和持续低DHA,或与成年早期精神病谱系症状(如精神病体验数量和阴性症状)相关。
- 但当前证据尚不足以支持将多不饱和脂肪酸轨迹作为精神病性障碍的预测指标,优化多不饱和脂肪酸状态对精神病症状的作用需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence supports associations between polyunsaturated fatty acids such as docosahexaenoic acid (DHA) and psychosis. However, polyunsaturated fatty acid trajectories in the general population have not been characterized, and associations with psychosis spectrum outcomes in early adulthood are unknown. METHODS: Plasma omega-6 to omega-3 ratio and DHA (expressed as percentage of total fatty acids) were measured by nuclear magnetic spectroscopy at 7, 15, 17, and 24 years of age in participants of ALSPAC (Avon Longitudinal Study of Parents and Children). Curvilinear growth mixture modeling evaluated body mass index-adjusted trajectories of both measures. Outcomes were assessed at 24 years. Psychotic experiences (PEs), at-risk mental state status, psychotic disorder, and number of PEs were assessed using the Psychosis-Like Symptoms interview (n = 3635; 2247 [61.8%] female). Negative symptoms score was measured using the Community Assessment of Psychic Experiences (n = 3484; 2161 [62.0%] female). Associations were adjusted for sex, ethnicity, parental social class, and cumulative smoking and alcohol use. RESULTS: Relative to stable average, the persistently high omega-6 to omega-3 ratio trajectory was associated with increased odds of PEs and psychotic disorder, but attenuated on adjustment for covariates (PEs adjusted odds ratio [aOR] = 1.63, 95% CI = 0.92-2.89; psychotic disorder aOR = 1.69, 95% CI = 0.71-4.07). This was also the case for persistently low DHA (PEs aOR = 1.42, 95% CI = 0.84-2.37; psychotic disorder aOR = 1.14, 95% CI = 0.49-2.67). Following adjustment, persistently high omega-6 to omega-3 ratio was associated with increased number of PEs (β = 0.41, 95% CI = 0.05-0.78) and negative symptoms score (β = 0.43, 95% CI = 0.14-0.72), as was persistently low DHA (number of PEs β = 0.45, 95% CI = 0.14-0.76; negative symptoms β = 0.35, 95% CI = 0.12-0.58). CONCLUSIONS: Optimization of polyunsaturated fatty acid status during development warrants further investigation in relation to psychotic symptoms in early adulthood.
引用
- Mongan D, Perry BI, Healy C, et al. Longitudinal Trajectories of Plasma Polyunsaturated Fatty Acids and Associations With Psychosis Spectrum Outcomes in Early Adulthood. Biol Psychiatry. 2024. PMID: 38631425. doi:10.1016/j.biopsych.2024.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。